SCHEMBL8693785

SCHEMBL8693785

O=C(Nc1ccccc1)Nc1nn(Cc2ccccc2)cc1C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.53
ADORA2B P29275 2/20 0.53
ADORA1 P30542 2/20 0.53
PPIA P62937 6/20 0.47
ALDH1A1 P00352 2/20 0.43
POLB P06746 2/20 0.43
TDP1 Q9NUW8 1/20 0.42
ADORA2A P29274 1/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8698039 0.90 ADORA3 (0.52) ADORA3ADORA2BADORA1PPIAALDH1A1
SCHEMBL8698699 0.86 ADORA3 (0.58) ADORA3ADORA2BADORA1PPIAALDH1A1
SCHEMBL8693552 0.78 MAPT (0.54) ADORA3ALDH1A1POLBKMT2ARAB9A
SCHEMBL8696343 0.78 ALDH1A1 (0.47) PPIAALDH1A1POLBRAB9AGAA
SCHEMBL8693623 0.77 ALDH1A1 (0.48) ADORA3ADORA1PPIAALDH1A1POLB
SCHEMBL8698728 0.77 ALDH1A1 (0.48) ADORA3ADORA1PPIAALDH1A1POLB
SCHEMBL8593357 0.77 ALDH1A1 (0.48) PPIAALDH1A1POLB
SCHEMBL8696823 0.77 ALDH1A1 (0.46) ADORA3ADORA2BADORA1PPIAALDH1A1
SCHEMBL8696191 0.76 EPHX1 (0.47) ALDH1A1POLBKMT2ARAB9AGAA
SCHEMBL8693064 0.76 ALDH1A1 (0.52) ALDH1A1POLBTDP1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5849779-A Pyrazole derivatives and their pharmaceutical use JAPAN ENERGY CORPORATION (JP) 1998-12-15 US disclosed
EP-0810217-A1 Pyrazole derivatives and their pharmaceutical use as smooth muscle cell growth inhibitors JAPAN ENERGY CORPORATION (JP) 1997-12-03 EP disclosed